Systematic analysis of berberine-induced signaling pathway between miRNA clusters and mRNAs and identification of mir-99a∼125b cluster function by seed-targeting inhibitors in multiple myeloma cells

Characterization of p38 MAPK isoforms for drug resistance study using systems biology approach

(2014) Huiming Peng et al.   BIOINFORMATICS

Composition of seed sequence is a major determinant of microRNA targeting patterns

(2014) X. Wang   BIOINFORMATICS

MicroRNA and Multiple Myeloma: from Laboratory Findings to Translational Therapeutic Approaches

(2014) Marco Rossi et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer

(2014) Parham Jabbarzadeh Kaboli et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The impact of C-Myc gene-related aberrations in newly diagnosed myeloma with bortezomib/dexamethasone therapy

(2014) Naohiro Sekiguchi et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

p53 haploinsufficiency and functional abnormalities in multiple myeloma

(2014) P J Teoh et al.   LEUKEMIA

Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma

(2014) M Affer et al.   LEUKEMIA

Regulation of p53-targeting microRNAs by polycyclic aromatic hydrocarbons: Implications in the etiology of multiple myeloma

(2014) Michael W. Gordon et al.   MOLECULAR CARCINOGENESIS

Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression

(2013) Megan Murray et al.   CELL CYCLE

miRNAs in Cancer Prevention and Treatment and as Molecular Targets for Natural Product Anticancer Agents

(2013) Biyun Qian et al.   CURRENT CANCER DRUG TARGETS

Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells

(2013) D Sun et al.   ONCOGENE

MicroRNA-21-3p, a Berberine-Induced miRNA, Directly Down-Regulates Human Methionine Adenosyltransferases 2A and 2B and Inhibits Hepatoma Cell Growth

(2013) Ting-Fang Lo et al.   PLoS One

Set9, NF-κB and microRNA-21 mediate berberine-induced apoptosis of human multiple myeloma cells

(2012) Hai-yan Hu et al.   ACTA PHARMACOLOGICA SINICA

The Role of CD19 and CD27 in the Diagnosis of Multiple Myeloma by Flow Cytometry

(2012) Elisa Cannizzo et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin function

(2012) David García-Bernal et al.   JOURNAL OF PATHOLOGY

MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R

(2012) J Gong et al.   ONCOGENE

Targeting p53 via JNK Pathway: A Novel Role of RITA for Apoptotic Signaling in Multiple Myeloma

(2012) Manujendra N. Saha et al.   PLoS One

MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia

(2011) D. Schotte et al.   HAEMATOLOGICA

Stromal cells and CD40 ligand (CD154) alter the miRNome and induce miRNA clusters including, miR-125b/miR-99a/let-7c and miR-17-92 in chronic lymphocytic leukaemia

(2011) S Willimott et al.   LEUKEMIA

Silencing of microRNA families by seed-targeting tiny LNAs

(2011) Susanna Obad et al.   NATURE GENETICS

Drug Inhibition Profile Prediction for NFκB Pathway in Multiple Myeloma

(2011) Huiming Peng et al.   PLoS One

Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development

(2010) Flavia Pichiorri et al.   CANCER CELL

Negative regulation of the tumor suppressor p53 gene by microRNAs

(2010) M Kumar et al.   ONCOGENE

RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma

(2009) A. K. Azab et al.   BLOOD

Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma

(2009) M. Lionetti et al.   BLOOD

Pharmacological activation of the p53 pathway in haematological malignancies

(2009) M. N Saha et al.   JOURNAL OF CLINICAL PATHOLOGY

Multiple myeloma

(2009) Marc S Raab et al.   LANCET

Berberine inhibits TPA-induced MMP-9 and IL-6 expression in normal human keratinocytes

(2007) Sangmin Kim et al.   PHYTOMEDICINE